Newman ferrara llp announces corporate governance investigations of sensei biotherapeutics, inc. (snse)

New york--( business wire )--newman ferrara llp announced today that the firm is conducting investigations on behalf of shareholders of sensei biotherapeutics, inc. (nasdaq:snse) (“sensei” or the “company”). the investigations concern whether certain of the sensei's officers and directors breached their fiduciary duties to shareholders, by, among other things: (i) engaging in self-dealing; (ii) affirmatively approving transactions that harmed the company; and (iii) failing to provide sufficient oversight of the company's business practices.
SNSE Ratings Summary
SNSE Quant Ranking